Mortality nearly halved with dual antiplatelet therapy in severe PAD

WASHINGTON – Long-term dual-antiplatelet therapy may provide a mortality benefit over aspirin alone in patients with symptomatic peripheral artery disease.

In an observational study of 629 patients...